Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Fabio Efficace

Fabio Efficace

Italian Group for Adult Hematologic Diseases (GIMEMA)
Short-term patient-reported adverse events & HRQoL by CAR-T product in aggressive B-cell lymphomas 1:12
Short-term patient-reported adverse events & HRQoL by CAR-T product in aggressive B-cell lymphomas
Fabio Efficace • 14 Jun 2025
The burden of disease in patients with VEXAS syndrome and the need for further research 0:54
The burden of disease in patients with VEXAS syndrome and the need for further research
Fabio Efficace • 14 Jun 2025
Considering patient-reported fatigue in MDS: a novel prognostic index 0:59
Considering patient-reported fatigue in MDS: a novel prognostic index
Fabio Efficace • 14 Jun 2025
The importance of timely reporting of patient-reported outcomes in clinical trials 3:29
The importance of timely reporting of patient-reported outcomes in clinical trials
Fabio Efficace • 12 Mar 2025
The importance of integrating quality of life assessment into clinical trials and routine practice 1:51
The importance of integrating quality of life assessment into clinical trials and routine practice
Fabio Efficace • 12 Mar 2025
A pooled analysis of baseline health-related QoL in patients with AML, APL, and MDS 2:41
A pooled analysis of baseline health-related QoL in patients with AML, APL, and MDS
Fabio Efficace • 6 Dec 2024
A study investigating the prognostic value of self-reported fatigue in newly diagnosed MDS 2:11
A study investigating the prognostic value of self-reported fatigue in newly diagnosed MDS
Fabio Efficace • 6 Dec 2024
Updates in LR-MDS treatment: imetelstat and luspatercept, standardizing PROs, and using AI to improve risk stratification
Adrián Mosquera Orgueira et al. • 17 Jul 2024
The prognostic value of patient-reported outcomes in MDS 1:30
The prognostic value of patient-reported outcomes in MDS
Fabio Efficace • 5 May 2023
Developing effective methods to study QoL in clinical trials in MDS 2:48
Developing effective methods to study QoL in clinical trials in MDS
Fabio Efficace • 5 May 2023
The prognostic value of self-reported fatigue on overall survival in patients with MDS 1:06
The prognostic value of self-reported fatigue on overall survival in patients with MDS
Fabio Efficace • 5 May 2023
BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDS 0:59
BMT CTN 1102: pre-transplantation QoL measures improve prognostication in HR-MDS
Fabio Efficace • 5 May 2023
Patient-reported outcome measures for MDS: EORTC QLQ-C30 & QUALMS 0:49
Patient-reported outcome measures for MDS: EORTC QLQ-C30 & QUALMS
Fabio Efficace • 5 May 2023
Difference between quality of life & patient-reported outcomes 0:45
Difference between quality of life & patient-reported outcomes
Fabio Efficace • 5 May 2023
The content of VJHemOnc is intended for healthcare professionals